Director, Industrial Hygiene at Bristol-Myers Squibb

Lawrence Township, New Jersey, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, Biotechnology, HealthcareIndustries

Requirements

Proven track record of managing industrial hygiene programs at a global scale
Forward-thinking leadership skills to drive continuous improvement and create a safety-first culture
Subject matter mastery and current industry knowledge in industrial hygiene (e.g., Air Contaminants, Chemical Exposure, Physical Hazards like Noise and Radiation, Ergonomics, Biosafety)
Ability to partner with S-CoE colleagues, senior leadership, global/site teams, and operational departments

Responsibilities

Develop and lead the global strategy for industrial hygiene, ensuring alignment with company objectives and regulatory requirements
Develop and drive implementation of holistic, corporate-wide programs and plans for Industrial Hygiene (including Biosafety, Ergonomics, Radiation Safety, etc.), ensuring risk management, exposure control, compliance verification, and a culture of continual improvement
Ensure suitable systems, programs, and policies for identification, assessment, management, and control of exposure to hazardous chemical and biological materials, including scientifically-sound health hazard assessments
Maintain subject matter expertise and provide technical guidance to business units, manufacturing sites, research/development laboratories, and global project teams to ensure consistency and best practices
Build and maintain relationships with senior leadership, business units, sites, and functional teams, providing interpretation and expert advice on industrial hygiene issues to drive decision-making and performance
Collaborate with site EHS, Engineering, Facilities, and operations staff to design and implement controls for exposure reduction, containment, and operational efficiency; leverage industry partnerships for innovation and best practices
Define resources and competencies, develop and deliver training programs, build networks and communities

Skills

Industrial Hygiene

Air Contaminants

Chemical Exposure

Physical Hazards

Noise Control

Radiation Safety

Ergonomics

Biosafety

EHS Compliance

Risk Assessment

Program Development

Regulatory Compliance

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free